Nevadistinel structure
|
Common Name | Nevadistinel | ||
|---|---|---|---|---|
| CAS Number | 2181816-92-0 | Molecular Weight | 274.32 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C15H18N2O3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of NevadistinelNevadistinel (NYX-458; NYX-3054) is a positive allosteric modulator of N-methyl-D-aspartate (NMDA) receptor. Nevadistinel can be used to inhibit cognitive impairment associated with neurodegenerative diseases, such as mild cognitive impairment, mild Alzheimer's disease, Parkinson's disease, Lewy body disease[1]. |
| Name | Nevadistinel |
|---|
| Description | Nevadistinel (NYX-458; NYX-3054) is a positive allosteric modulator of N-methyl-D-aspartate (NMDA) receptor. Nevadistinel can be used to inhibit cognitive impairment associated with neurodegenerative diseases, such as mild cognitive impairment, mild Alzheimer's disease, Parkinson's disease, Lewy body disease[1]. |
|---|---|
| Related Catalog | |
| Target |
NMDA receptor[1] |
| References |
| Molecular Formula | C15H18N2O3 |
|---|---|
| Molecular Weight | 274.32 |